Observational Pregnancy Surveillance Program of Patients Exposed to Epidiolex®/Epidyolex® During Pregnancy to Assess the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant

21/11/2023
18/10/2024
EU PAS number:
EUPAS107705
Study
Planned
Documents
Study protocol
Study results
Study report
Other information